abstract
- Ghosn L, Chaimani A, Evrenoglou T, et al. Interleukin-6 blocking agents for treating COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021;3:CD013881. 33734435.
In COVID-19, tocilizumab reduces all-cause mortality at 28 d
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
authors
status
publication date
- June 2021
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Antibodies, Monoclonal, Humanized (MeSH)
- COVID-19 Drug Treatment (MeSH)
- Humans (MeSH)
- Interleukin-6 (MeSH)
- SARS-CoV-2 (MeSH)
published in
- ACP journal club Journal